News Releases

News Releases

Share
Print
Share
Print
and/or
349 News Releases found

MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

  • Thursday, July 15, 2021

MSK Leaders Recognized in Crain’s New York Business 2021 Notable in Health Care List

Dr. Craig Thompson, Dr. Peter Bach, Dr. Ushma Neill, and Dr. William Rosa were recognized for their professional, civic, and philanthropic achievements.

  • Monday, July 12, 2021

Cycle for Survival Raises $285 Million in 15 Years

With founding partner Equinox, Cycle for Survival surpasses $285 million raised since 2007; every dollar funds rare cancer research led by Memorial Sloan Kettering Cancer Center.

  • Monday, June 21, 2021

MSK Awards & Appointments

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

  • Friday, June 18, 2021

Marking the Milestone, Celebrating the Achievement: MSK Kids Hosts 15th Annual Pediatric Convocation

For the 15th year, MSK honored the academic achievements of our youngest patients by hosting MSK Kids Convocation - a virtual ceremony to help mark and celebrate the end of their adolescent school years.

  • Friday, June 11, 2021

ASCO 2021: PSMA-Targeted Radioligand Therapy Improves Survival in Metastatic Prostate Cancer

New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).

  • Thursday, June 3, 2021

ASCO 2021: MSK Experts Featured at the American Society of Clinical Oncology Annual Meeting

The 2021 ASCO Annual Meeting will bring together one of the largest, most diverse audiences in oncology and provide engaging broadcast and on-demand presentations of the latest cutting-edge oncology research. ASCO 2021 will focus on Equity: Every Patient. Every Day. Everywhere.

  • Wednesday, June 2, 2021

Immunotherapy after Bladder Cancer Surgery May Reduce Recurrence, Study Shows

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence. This research was published today in the New England Journal of Medicine.

  • Wednesday, June 2, 2021

A. Thomas Look, MD, Named 2021 Society of Memorial Sloan Kettering Prize Recipient for Contributions in Pediatric Oncology

The global prize is awarded annually to a researcher, physician, or team leader who has made a positive and lasting impact in the fight against pediatric cancer.

  • Thursday, May 20, 2021

Get HPV Vaccinations Back on Track, MSK and Other NCI Designated Cancer Centers Urge

MSK is proud to join with National Cancer Institute (NCI)-designated cancer centers and other organizations to launch an awareness initiative urging the nation’s physicians, parents and young adults to get the human papillomavirus (HPV) vaccination back on track.

  • Thursday, May 20, 2021